STONINGTON PARTNERS INC II
CIK 1047030 · last filed 2010-12-02
STONINGTON PARTNERS INC II is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2009. The most recent filing shows the insider sold $52.9M of OMPI on Dec 2, 2010. Across all open-market trades the lifetime net is −$100.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $87.7M across reported positions. The firm reports its address in New York, NY. 15 SEC filings were submitted jointly with James J Burke Jr.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OMPI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NEW YORK, NY 10153
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Obagi Medical Products, Inc. (OMPI) Delisted | 10%+ Owner | 0 | — | — | -$52.91M | 1 | 2010-12-02 |
| LINC | 10%+ Owner | 3,921,441 | $22.37 | $87.72M | -$47.14M | 3 | 2010-04-08 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-12-02 | Obagi Medical Products, Inc. (OMPI) Delisted | Sell (S) | −5,377,336 | -$52.91M | EDGAR |
| 2010-04-08 | LINC | Sell (S) | −12,000,000 | $0 | EDGAR |
| 2009-12-17 | LINC | Sell (S) | −2,250,000 | -$47.14M | EDGAR |
| 2009-02-20 | LINC | Sell (S) | −13,972,500 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.